News Headline Summary

FDA advisory panel vote 18 to 0 for J&J drug

Says:
- Data supports the efficacy of J&J drug Bedaquiline against resistant TB.

Reaction details:

- No immediate reaction to the news, last trade at USD 69.25 (+0.65%).

Print 20:55, 28 Nov 2012 - US Equities - Source: Newswires